NOVO Trademark

Trademark Overview

On Friday, April 21, 2017, a trademark application was filed for NOVO with the United States Patent and Trademark Office. The USPTO has given the NOVO trademark a serial number of 79214800. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Monday, February 10, 2025. This trademark is owned by Novo Nordisk A/S. The NOVO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of diabetes, obesity, cardiovascular diseases, endocrine diseases and disorders, hormonal diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, and blood disorders
novo

General Information

Serial Number79214800
Word MarkNOVO
Filing DateFriday, April 21, 2017
Status706 - SECTION 71 ACCEPTED
Status DateMonday, February 10, 2025
Registration Number5494605
Registration DateTuesday, June 19, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 3, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of diabetes, obesity, cardiovascular diseases, endocrine diseases and disorders, hormonal diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, and blood disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 25, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovo Nordisk A/S
Party Type30 - Original Registrant
Legal Entity Type84 - NOT AVAILABLE
AddressBagsvaerd DK-2880
DK
Party NameNovo Nordisk A/S
Party Type20 - Owner at Publication
Legal Entity Type84 - NOT AVAILABLE
AddressDK
Party NameNovo Nordisk A/S
Party Type10 - Original Applicant
Legal Entity Type84 - NOT AVAILABLE
AddressDK

Trademark Events

Event DateEvent Description
Friday, September 15, 2017REFUSAL PROCESSED BY IB
Thursday, August 24, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, August 25, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 25, 2017ASSIGNED TO EXAMINER
Monday, August 28, 2017NON-FINAL ACTION WRITTEN
Tuesday, August 29, 2017APPLICATION FILING RECEIPT MAILED
Tuesday, August 29, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, August 30, 2017REFUSAL PROCESSED BY MPU
Wednesday, August 30, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, September 22, 2018FINAL DISPOSITION PROCESSED
Wednesday, January 3, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 3, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 3, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 1, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 14, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 3, 2018PUBLISHED FOR OPPOSITION
Tuesday, April 3, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 19, 2018REGISTERED-PRINCIPAL REGISTER
Wednesday, September 19, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, February 10, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, February 10, 2025REGISTERED-SEC.71 ACCEPTED
Monday, February 10, 2025NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Saturday, September 22, 2018FINAL DISPOSITION NOTICE SENT TO IB
Friday, October 12, 2018FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, June 19, 2023COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Tuesday, August 20, 2024TEAS SECTION 71 RECEIVED

Related Keywords

novo disorders diseases kidney hormonal liver metabolic blood preparations endocrine diabetes